{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T16:09:08Z","timestamp":1791648548257,"version":"4.3.4"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revista Brasileira de Psiquiatria"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/s1516-4446(12)70057-0","type":"journal-article","created":{"date-parts":[[2012,12,20]],"date-time":"2012-12-20T20:13:56Z","timestamp":1356034436000},"page":"S104-S117","source":"Crossref","is-referenced-by-count":89,"special_numbering":"S1","title":["Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug"],"prefix":"10.1016","volume":"34","author":[{"given":"Alexandre Rafael de Mello","family":"Schier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia Pinho de Oliveira","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana Cardoso de Oliveira","family":"e Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime Eduardo Cecilio","family":"Hallak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Alexandre S.","family":"Crippa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio E.","family":"Nardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Waldo","family":"Zuardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/S1516-4446(12)70057-0_bib1","first-page":"S41","article-title":"[Cannabis abuse in patients with psychiatric disorders: an update to old evidence]","volume":"32","author":"Diehl","year":"2010","journal-title":"Rev Bras Psiquiatr"},{"key":"10.1016\/S1516-4446(12)70057-0_bib2","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1126\/science.168.3936.1159","article-title":"Marihuana chemistry","volume":"168","author":"Mechoulam","year":"1970","journal-title":"Science"},{"key":"10.1016\/S1516-4446(12)70057-0_bib3","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1126\/science.169.3945.611","article-title":"Chemical basis of hashish activity","volume":"169","author":"Mechoulam","year":"1970","journal-title":"Science"},{"key":"10.1016\/S1516-4446(12)70057-0_bib4","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/00008877-200509000-00023","article-title":"Neurophysiologicaland subjective profile of marijuana with varying concentrationsof cannabinoids","volume":"16","author":"Ilan","year":"2005","journal-title":"Behav Pharmacol"},{"issue":"7","key":"10.1016\/S1516-4446(12)70057-0_bib5","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/hup.1048","article-title":"Cannabis and anxiety: a critical review of the evidence","volume":"24","author":"Crippa","year":"2009","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/S1516-4446(12)70057-0_bib6","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1002\/cbdv.200790147","article-title":"Cannabidiol - recent advances","volume":"4","author":"Mechoulam","year":"2007","journal-title":"Chem Biodivers"},{"key":"10.1016\/S1516-4446(12)70057-0_bib7","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF00432554","article-title":"Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects","volume":"76","author":"Zuardi","year":"1982","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"10.1016\/S1516-4446(12)70057-0_bib8","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1590\/S0100-879X2006000400001","article-title":"Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug","volume":"39","author":"Zuardi","year":"2006","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/S1516-4446(12)70057-0_bib9","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/BF02244012","article-title":"Antianxiety effect of cannabidiol in the elevated plus-maze","volume":"100","author":"Guimar\u00e3es","year":"1990","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/S1516-4446(12)70057-0_bib10","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.bbr.2006.05.016","article-title":"Effects of cannabidiol and diazepam on behavioral and cardiovascular responses induced by contextual conditioned fear in rats","volume":"172","author":"Resstel","year":"2006","journal-title":"Behav Brain Res"},{"issue":"1","key":"10.1016\/S1516-4446(12)70057-0_bib11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1476-5381.2008.00046.x","article-title":"5-HT1A receptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in ratscardiovascular responses to acute restraint stress in rats","volume":"156","author":"Resstel","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/S1516-4446(12)70057-0_bib12","doi-asserted-by":"crossref","first-page":"PL1","DOI":"10.1016\/S0024-3205(98)00238-0","article-title":"Complex pharmacology of natural cannabinoids: evidence for partial agonist activity of delta9-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptors","volume":"63","author":"Petitet","year":"1998","journal-title":"Life Sci"},{"key":"10.1016\/S1516-4446(12)70057-0_bib13","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0022-3565(24)37365-3","article-title":"Comparative receptor binding analyses of cannabinoid agonists and antagonists","volume":"285","author":"Thomas","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"issue":"8","key":"10.1016\/S1516-4446(12)70057-0_bib14","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s11064-005-6978-1","article-title":"Agonistic properties of cannabidiol at 5-HT1a receptors","volume":"30","author":"Russo","year":"2005","journal-title":"Neurochem Res"},{"key":"10.1016\/S1516-4446(12)70057-0_bib15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00213-008-1168-x","article-title":"Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats","volume":"199","author":"Campos","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"10.1016\/S1516-4446(12)70057-0_bib16","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1017\/S1461145709990617","article-title":"Modulation of effective connectivity during emotional processing by Delta(9)-tetrahydrocannabinol and cannabidiol","volume":"13","author":"Fusar-Poli","year":"2010","journal-title":"Int J Neuropsychopharmacol"},{"issue":"1","key":"10.1016\/S1516-4446(12)70057-0_bib17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/0269881110379283","article-title":"Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report","volume":"25","author":"Crippa","year":"2011","journal-title":"J Psychopharmacol"},{"key":"10.1016\/S1516-4446(12)70057-0_bib18","first-page":"25","article-title":"Comparative effects between cannabidiol and diazepam on neophobia, food intake and conflict behavior","volume":"6","author":"Silveira Filho","year":"1981","journal-title":"Res Commun Psychol Psychiatry Behav"},{"key":"10.1016\/S1516-4446(12)70057-0_bib19","first-page":"391","article-title":"Changes in the conditioned emotional response of rats induced by \u03949-THC. CBD and mixture of the two cannabinoids","volume":"26","author":"Zuardi","year":"1983","journal-title":"Arq Biol Tecnol"},{"issue":"3","key":"10.1016\/S1516-4446(12)70057-0_bib20","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0022-3565(25)13195-9","article-title":"Pharmacological characterization of cannabinoids in the elevated plus maze","volume":"253","author":"Onaivi","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"issue":"8","key":"10.1016\/S1516-4446(12)70057-0_bib21","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.pnpbp.2009.08.017","article-title":"Evidence for a potential role for TRPV1 receptors in the dorsolateral periaqueductal gray in the attenuation of the anxiolytic effects of cannabinoids","volume":"33","author":"Campos","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"8","key":"10.1016\/S1516-4446(12)70057-0_bib22","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.pnpbp.2006.06.004","article-title":"Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test","volume":"30","author":"Moreira","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"2","key":"10.1016\/S1516-4446(12)70057-0_bib23","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.bbr.2010.05.004","article-title":"Intra-dorsal periaqueductal gray administration of cannabidiol blocks panic-like response by activating 5-HT1A receptors","volume":"213","author":"Soares","year":"2010","journal-title":"Behav Brain Res"},{"key":"10.1016\/S1516-4446(12)70057-0_bib24","unstructured":"Campos AC, Soares Vde P, Carvalho MC, Ferreira FR, Vicente MA, Brand\u00e3o ML, Zuardi AW, Zangrossi JR. H, Guimar\u00e3es FS. Cannabidiol chronic treatment attenuates panic-like responses via direct modulation of 5HT1A receptors functions in the dorsal periaqueductal grey matter. Neuropsychopharmacology (submitted)."},{"issue":"4","key":"10.1016\/S1516-4446(12)70057-0_bib25","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.bjp.0704327","article-title":"Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide","volume":"134","author":"Bisogno","year":"2001","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10.1016\/S1516-4446(12)70057-0_bib26","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/FBP.0b013e32833b33c5","article-title":"Cannabidiol inhibitory effect on marble-burying behaviour: involvement of CB1 receptors","volume":"21","author":"Casarotto","year":"2010","journal-title":"Behav Pharmacol"},{"issue":"3","key":"10.1016\/S1516-4446(12)70057-0_bib27","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00213-011-2415-0","volume":"219","author":"Deiana","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"issue":"12","key":"10.1016\/S1516-4446(12)70057-0_bib28","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.euroneuro.2008.07.001","article-title":"Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned rats","volume":"18","author":"Bitencourt","year":"2008","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1","key":"10.1016\/S1516-4446(12)70057-0_bib29","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbr.2009.09.045","article-title":"Involvement of the prelimbic prefrontal cortex on cannabidiol-induced attenuation of contextual conditioned fear in rats","volume":"207","author":"Lemos","year":"2010","journal-title":"Behav Brain Res"},{"issue":"2\u20133","key":"10.1016\/S1516-4446(12)70057-0_bib30","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00213-010-2036-z","article-title":"The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors","volume":"213","author":"Gomes","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/S1516-4446(12)70057-0_bib31","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/npp.2011.188","article-title":"Anti-aversive effects of cannabidiol on innate fear-induced behaviors evoked by an ethological model of panic attacks based on a prey vs the wild snake Epicrates cenchria crassus confrontation paradigm","volume":"37","author":"Uribe-Mari\u00f1o","year":"2012","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/S1516-4446(12)70057-0_bib32","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1177\/026988119300700112","article-title":"Effects of ipsapirone and cannabidiol on human experimental anxiety","volume":"7","author":"Zuardi","year":"1993","journal-title":"J Psychopharmacol"},{"issue":"6","key":"10.1016\/S1516-4446(12)70057-0_bib33","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/npp.2011.6","article-title":"Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Na\u00efve Social Phobia Patients","volume":"36","author":"Bergamaschi","year":"2011","journal-title":"Neuropsychopharmacol"},{"issue":"2","key":"10.1016\/S1516-4446(12)70057-0_bib34","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/sj.npp.1300340","article-title":"Effects of cannabidiol (CBD) on regional cerebral blood flow","volume":"29","author":"Crippa","year":"2004","journal-title":"Neuropsychopharmacol"},{"issue":"1","key":"10.1016\/S1516-4446(12)70057-0_bib35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1001\/archgenpsychiatry.2008.519","article-title":"Distinct effects of D9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing","volume":"66","author":"Fusar-Poli","year":"2009","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"10.1016\/S1516-4446(12)70057-0_bib36","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2174\/157488611798280924","article-title":"Safety and side effects of cannabidiol, a Cannabis sativa constituent","volume":"6","author":"Bergamaschi","year":"2011","journal-title":"Curr Drug Saf"},{"issue":"Suppl1","key":"10.1016\/S1516-4446(12)70057-0_bib37","first-page":"S56","article-title":"[Therapeutical use of the cannabinoids in psychiatry]","volume":"32","author":"Crippa","year":"2010","journal-title":"Rev Bras Psiquiatr"},{"issue":"3","key":"10.1016\/S1516-4446(12)70057-0_bib38","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1590\/S1516-44462008000300015","article-title":"Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action","volume":"30","author":"Zuardi","year":"2008","journal-title":"Rev Bras Psiquiatr"},{"issue":"10","key":"10.1016\/S1516-4446(12)70057-0_bib39","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.tips.2009.07.006","article-title":"Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb","volume":"30","author":"Izzo","year":"2009","journal-title":"Trends Pharmacol Sci"},{"issue":"Suppl 1","key":"10.1016\/S1516-4446(12)70057-0_bib40","first-page":"S51","article-title":"Cannabis sativa: the plant that can induce unwanted effects and also treat them","volume":"32","author":"Crippa","year":"2010","journal-title":"Rev Bras Psiquiatr"},{"issue":"Suppl 1","key":"10.1016\/S1516-4446(12)70057-0_bib41","first-page":"S41","article-title":"[Cannabis abuse in patients with psychiatric disorders: an update to old evidence]","volume":"32","author":"Diehl","year":"2010","journal-title":"Rev Bras Psiquiatr"},{"key":"10.1016\/S1516-4446(12)70057-0_bib42","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1126\/science.168.3936.1159","article-title":"Marihuana chemistry","volume":"168","author":"Mechoulam","year":"1970","journal-title":"Science"},{"key":"10.1016\/S1516-4446(12)70057-0_bib43","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1126\/science.169.3945.611","article-title":"Chemical basis of hashish activity","volume":"169","author":"Mechoulam","year":"1970","journal-title":"Science"},{"key":"10.1016\/S1516-4446(12)70057-0_bib44","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/00008877-200509000-00023","article-title":"Neurophysiologicaland subjective profile of marijuana with varying concentrationsof cannabinoids","volume":"16","author":"Ilan","year":"2005","journal-title":"Behav Pharmacol"},{"issue":"7","key":"10.1016\/S1516-4446(12)70057-0_bib45","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/hup.1048","article-title":"Cannabis and anxiety: a critical review of the evidence","volume":"24","author":"Crippa","year":"2009","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/S1516-4446(12)70057-0_bib46","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1002\/cbdv.200790147","article-title":"Cannabidiol \u2013 recent advances","volume":"4","author":"Mechoulam","year":"2007","journal-title":"Chem Biodivers"},{"key":"10.1016\/S1516-4446(12)70057-0_bib47","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF00432554","article-title":"Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects","volume":"76","author":"Zuardi","year":"1982","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"10.1016\/S1516-4446(12)70057-0_bib48","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1590\/S0100-879X2006000400001","article-title":"Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug","volume":"39","author":"Zuardi","year":"2006","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/S1516-4446(12)70057-0_bib49","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/BF02244012","article-title":"Antianxiety effect of cannabidiol in the elevated plus-maze","volume":"100","author":"Guimar\u00e3es","year":"1990","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/S1516-4446(12)70057-0_bib50","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.bbr.2006.05.016","article-title":"Effects of cannabidiol and diazepam on behavioral and cardiovascular responses induced by contextual conditioned fear in rats","volume":"172","author":"Resstel","year":"2006","journal-title":"Behav Brain Res"},{"issue":"1","key":"10.1016\/S1516-4446(12)70057-0_bib51","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1476-5381.2008.00046.x","article-title":"5-HT1A receptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in ratscardiovascular responses to acute restraint stress in rats","volume":"156","author":"Resstel","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/S1516-4446(12)70057-0_bib52","doi-asserted-by":"crossref","first-page":"PL1","DOI":"10.1016\/S0024-3205(98)00238-0","article-title":"Complex pharmacology of natural cannabinoids: evidence for partial agonist activity of delta9-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptors","volume":"63","author":"Petitet","year":"1998","journal-title":"Life Sci"},{"key":"10.1016\/S1516-4446(12)70057-0_bib53","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0022-3565(24)37365-3","article-title":"Comparative receptor binding analyses of cannabinoid agonists and antagonists","volume":"285","author":"Thomas","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"issue":"8","key":"10.1016\/S1516-4446(12)70057-0_bib54","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s11064-005-6978-1","article-title":"Agonistic properties of cannabidiol at 5-HT1a receptors","volume":"30","author":"Russo","year":"2005","journal-title":"Neurochem Res"},{"key":"10.1016\/S1516-4446(12)70057-0_bib55","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00213-008-1168-x","article-title":"Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats","volume":"199","author":"Campos","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"10.1016\/S1516-4446(12)70057-0_bib56","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1017\/S1461145709990617","article-title":"Modulation of effective connectivity during emotional processing by Delta(9)-tetrahydrocannabinol and cannabidiol","volume":"13","author":"Fusar-Poli","year":"2010","journal-title":"Int J Neuropsychopharmacol"},{"issue":"1","key":"10.1016\/S1516-4446(12)70057-0_bib57","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/0269881110379283","article-title":"Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report","volume":"25","author":"Crippa","year":"2011","journal-title":"J Psychopharmacol"},{"key":"10.1016\/S1516-4446(12)70057-0_bib58","first-page":"25","article-title":"Comparative effects between cannabidiol and diazepam on neophobia, food intake and conflict behavior","volume":"6","author":"Silveira Filho","year":"1981","journal-title":"Res Commun Psychol Psychiatry Behav"},{"key":"10.1016\/S1516-4446(12)70057-0_bib59","first-page":"391","article-title":"Changes in the conditioned emotional response of rats induced by \u03949-THC. CBD and mixture of the two cannabinoids","volume":"26","author":"Zuardi","year":"1983","journal-title":"Arq Biol Tecnol"},{"issue":"3","key":"10.1016\/S1516-4446(12)70057-0_bib60","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0022-3565(25)13195-9","article-title":"Pharmacological characterization of cannabinoids in the elevated plus maze","volume":"253","author":"Onaivi","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"issue":"8","key":"10.1016\/S1516-4446(12)70057-0_bib61","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.pnpbp.2009.08.017","article-title":"Evidence for a potential role for TRPV1 receptors in the dorsolateral periaqueductal gray in the attenuation of the anxiolytic effects of cannabinoids","volume":"33","author":"Campos","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"8","key":"10.1016\/S1516-4446(12)70057-0_bib62","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.pnpbp.2006.06.004","article-title":"Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test","volume":"30","author":"Moreira","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"2","key":"10.1016\/S1516-4446(12)70057-0_bib63","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.bbr.2010.05.004","article-title":"Intra-dorsal periaqueductal gray administration of cannabidiol blocks panic-like response by activating 5-HT1A receptors","volume":"213","author":"Soares Vde","year":"2010","journal-title":"Behav Brain Res"},{"key":"10.1016\/S1516-4446(12)70057-0_bib64","unstructured":"Campos AC, Soares Vde P, Carvalho MC, Ferreira FR, Vicente MA, Brand\u00e3o ML, Zuardi AW, Zangrossi JR. H, Guimar\u00e3es FS. Cannabidiol chronic treatment attenuates panic-like responses via direct modulation of 5HT1A receptors functions in the dorsal periaqueductal grey matter. Neuropsychopharmacology (submitted)."},{"issue":"4","key":"10.1016\/S1516-4446(12)70057-0_bib65","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.bjp.0704327","article-title":"Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide","volume":"134","author":"Bisogno","year":"2001","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10.1016\/S1516-4446(12)70057-0_bib66","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/FBP.0b013e32833b33c5","article-title":"Cannabidiol inhibitory effect on marble-burying behaviour: involvement of CB1 receptors","volume":"21","author":"Casarotto","year":"2010","journal-title":"Behav Pharmacol"},{"issue":"3","key":"10.1016\/S1516-4446(12)70057-0_bib67","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00213-011-2415-0","volume":"219","author":"Deiana","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"issue":"12","key":"10.1016\/S1516-4446(12)70057-0_bib68","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.euroneuro.2008.07.001","article-title":"Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned rats","volume":"18","author":"Bitencourt","year":"2008","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1","key":"10.1016\/S1516-4446(12)70057-0_bib69","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbr.2009.09.045","article-title":"Involvement of the prelimbic prefrontal cortex on cannabidiol-induced attenuation of contextual conditioned fear in rats","volume":"207","author":"Lemos","year":"2010","journal-title":"Behav Brain Res"},{"issue":"2\u20133","key":"10.1016\/S1516-4446(12)70057-0_bib70","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00213-010-2036-z","article-title":"The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors","volume":"213","author":"Gomes","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/S1516-4446(12)70057-0_bib71","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/npp.2011.188","article-title":"Anti-aversive effects of cannabidiol on innate fear-induced behaviors evoked by an ethological model of panic attacks based on a prey vs the wild snake Epicrates cenchria crassus confrontation paradigm","volume":"37","author":"Uribe-Mari\u00f1o","year":"2012","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/S1516-4446(12)70057-0_bib72","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1177\/026988119300700112","article-title":"Effects of ipsapirone and cannabidiol on human experimental anxiety","volume":"7","author":"Zuardi","year":"1993","journal-title":"J Psychopharmacol"},{"issue":"6","key":"10.1016\/S1516-4446(12)70057-0_bib73","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/npp.2011.6","article-title":"Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Na\u00efve Social Phobia Patients","volume":"36","author":"Bergamaschi","year":"2011","journal-title":"Neuropsychopharmacol"},{"issue":"2","key":"10.1016\/S1516-4446(12)70057-0_bib74","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/sj.npp.1300340","article-title":"Effects of cannabidiol (CBD) on regional cerebral blood flow","volume":"29","author":"Crippa","year":"2004","journal-title":"Neuropsychopharmacol"},{"issue":"1","key":"10.1016\/S1516-4446(12)70057-0_bib75","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1001\/archgenpsychiatry.2008.519","article-title":"Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing","volume":"66","author":"Fusar-Poli","year":"2009","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"10.1016\/S1516-4446(12)70057-0_bib76","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2174\/157488611798280924","article-title":"Safety and side effects of cannabidiol, a Cannabis sativa constituent","volume":"6","author":"Bergamaschi","year":"2011","journal-title":"Curr Drug Saf"},{"issue":"Suppl1","key":"10.1016\/S1516-4446(12)70057-0_bib77","first-page":"S56","article-title":"[Therapeutical use of the cannabinoids in psychiatry]","volume":"32","author":"Crippa","year":"2010","journal-title":"Rev Bras Psiquiatr"},{"issue":"3","key":"10.1016\/S1516-4446(12)70057-0_bib78","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1590\/S1516-44462008000300015","article-title":"Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action","volume":"30","author":"Zuardi","year":"2008","journal-title":"Rev Bras Psiquiatr"},{"issue":"10","key":"10.1016\/S1516-4446(12)70057-0_bib79","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.tips.2009.07.006","article-title":"Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb","volume":"30","author":"Izzo","year":"2009","journal-title":"Trends Pharmacol Sci"},{"issue":"Suppl 1","key":"10.1016\/S1516-4446(12)70057-0_bib80","first-page":"S51","article-title":"Cannabis sativa: the plant that can induce unwanted effects and also treat them","volume":"32","author":"Crippa","year":"2010","journal-title":"Rev Bras Psiquiatr"}],"container-title":["Revista Brasileira de Psiquiatria"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1516444612700570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1516444612700570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T03:41:54Z","timestamp":1745466114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1516444612700570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":80,"aliases":["10.1590\/s1516-44462012000500008"],"alternative-id":["S1516444612700570"],"URL":"https:\/\/doi.org\/10.1016\/s1516-4446(12)70057-0","relation":{},"ISSN":["1516-4446"],"issn-type":[{"value":"1516-4446","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}